BioCentury
ARTICLE | Company News

Bioniche, UroCor sales and marketing update

March 12, 2001 8:00 AM UTC

BNC granted UCOR exclusive U.S. distribution rights to its Cystistat hyaluronic acid derivative for cystitis in exchange for a $750,000 upfront fee and up to $2.3 million in milestone payments. The c...